These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30474649)

  • 21. MARGINAL: An Automatic Classification of Variants in
    Karalidou V; Kalfakakou D; Papathanasiou A; Fostira F; Matsopoulos GK
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
    Momozawa Y; Sasai R; Usui Y; Shiraishi K; Iwasaki Y; Taniyama Y; Parsons MT; Mizukami K; Sekine Y; Hirata M; Kamatani Y; Endo M; Inai C; Takata S; Ito H; Kohno T; Matsuda K; Nakamura S; Sugano K; Yoshida T; Nakagawa H; Matsuo K; Murakami Y; Spurdle AB; Kubo M
    JAMA Oncol; 2022 Jun; 8(6):871-878. PubMed ID: 35420638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving beyond Bermuda: sharing data to build a medical information commons.
    Cook-Deegan R; McGuire AL
    Genome Res; 2017 Jun; 27(6):897-901. PubMed ID: 28373484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critique of "Evidence-Based Surgical Hypothesis: The case against BRCA1 and 2 testing".
    Nussbaum RL
    Surgery; 2012 Apr; 151(4):634-7. PubMed ID: 22306835
    [No Abstract]   [Full Text] [Related]  

  • 25. A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
    Gómez García EB; Oosterwijk JC; Timmermans M; van Asperen CJ; Hogervorst FB; Hoogerbrugge N; Oldenburg R; Verhoef S; Dommering CJ; Ausems MG; van Os TA; van der Hout AH; Ligtenberg M; van den Ouweland A; van der Luijt RB; Wijnen JT; Gille JJ; Lindsey PJ; Devilee P; Blok MJ; Vreeswijk MP
    Breast Cancer Res; 2009; 11(1):R8. PubMed ID: 19200354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The next 20 years of human genomics must be more equitable and more open.
    Nature; 2021 Feb; 590(7845):183-184. PubMed ID: 33568832
    [No Abstract]   [Full Text] [Related]  

  • 27. Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR).
    Lebo MS; Zakoor KR; Chun K; Speevak MD; Waye JS; McCready E; Parboosingh JS; Lamont RE; Feilotter H; Bosdet I; Tucker T; Young S; Karsan A; Charames GS; Agatep R; Spriggs EL; Chisholm C; Vasli N; Daoud H; Jarinova O; Tomaszewski R; Hume S; Taylor S; Akbari MR; Lerner-Ellis J;
    Genet Med; 2018 Mar; 20(3):294-302. PubMed ID: 28726806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of
    Dong H; Chandratre K; Qin Y; Zhang J; Tian X; Rong C; Wang N; Guo M; Zhao G; Wang SM
    J Med Genet; 2021 Aug; 58(8):565-569. PubMed ID: 32467295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
    Jacobs C; Pichert G; Harris J; Tucker K; Michie S
    Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
    Abul-Husn NS; Soper ER; Odgis JA; Cullina S; Bobo D; Moscati A; Rodriguez JE; ; ; Loos RJF; Cho JH; Belbin GM; Suckiel SA; Kenny EE
    Genome Med; 2019 Dec; 12(1):2. PubMed ID: 31892343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
    Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
    Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in classification of genetic variants in BRCA1 and BRCA2.
    Kast K; Wimberger P; Arnold N
    Arch Gynecol Obstet; 2018 Feb; 297(2):279-280. PubMed ID: 29302806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.
    Haddad JM; Robison K; Beffa L; Laprise J; ScaliaWilbur J; Raker CA; Clark MA; Hofstatter E; Dalela D; Brown A; Bradford L; Toland M; Stuckey A
    J Genet Couns; 2021 Dec; 30(6):1570-1581. PubMed ID: 33904624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
    Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
    Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Lee A; Moon BI; Kim TH
    Ann Lab Med; 2020 Mar; 40(2):114-121. PubMed ID: 31650727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
    Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
    BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRCA testing is important for our patients.
    Anderson BO; Javid SH; Calhoun KE; Byrd DR
    Surgery; 2012 Apr; 151(4):637-8. PubMed ID: 22306834
    [No Abstract]   [Full Text] [Related]  

  • 39. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.